Perioperative anti-vascular endothelial growth factor agents treatment in patients undergoing vitrectomy for complicated proliferative diabetic retinopathy: a network meta-analysis

Currently, controversies regarding the optimal time-point of anti-vascular endothelial growth factor (VEGF) pretreatment before pars plana vitrectomy (PPV) for proliferative diabetic retinopathy (PDR) still exist. To clarify this, we conducted a network meta-analysis, 26 randomized controlled trials...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Dong-yue, Zhao, Xin-yu, Zhang, Wen-fei, Meng, Li-hui, Chen, You-xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641141/
https://www.ncbi.nlm.nih.gov/pubmed/33144606
http://dx.doi.org/10.1038/s41598-020-75896-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641141/
https://www.ncbi.nlm.nih.gov/pubmed/33144606
http://dx.doi.org/10.1038/s41598-020-75896-8

Ejemplares similares